Srivats Rajagopal explores the growth of the antibody-body conjugate (ADC) market, development trends and why innovators are turning towards India. The ADC field has reached an…
News Category: Media
Mechanistic insights into PROTAC-mediated degradation through an integrated framework of molecular dynamics, free energy landscapes, and quantum mechanics: A case study on kinase degraders
Abstract Targeted protein degradation by proteolysis-targeting chimeras (PROTAC) is dependent on formation and plasticity of ternary complexes enabling ubiquitination. In this study, we employed long-timescale…
Incidence of Spontaneous and Urethane-Induced Tumors in a 26-Week Carcinogenicity Study in Tg.rasH2 Mice Sourced From CLEA, Japan
Abstract The Tg.rasH2 mouse is a validated bioassay system for evaluation of carcinogenic potential, and it is confirmed to be sensitive to both genotoxic and…
Aragen shares 2026 predictions
European Pharmaceutical Manufacturer spoke to Ashu Tandon, CCO, Aragen at CPHI Frankfurt about their 2026 predictions for the company. 1. We’re seeing early signs of…
Aragen Life Sciences: Trusted R&D and Manufacturing Partner
Scientific research plays a vital role in improving healthcare, and organizations that combine innovation with collaboration are driving progress in drug discovery. Among them is Aragen…
Aragen Bioscience CEO talks Bangalore expansion and Indian biomanufacturing
The JP Morgan Healthcare Conference last month brought together life science experts from around the world, enabling stakeholders such as developers, contract development and manufacturing…
Into the HPAPI Space and Beyond with Aragen Life Sciences
Highly potent active pharmaceutical ingredients, or HPAPIs, are a top current area of focus for India-based Aragen Life Sciences. At the Drug, Chemical & Associated Technologies…
India’s race for the CDMO crown
For years, China+1 has been the big story in India’s CDMO opportunity. Now, it is no longer enough. The shift away from China is well…
GVK BIO Launches Mobile App
Contact E: corpcomm@aragen.com
CFI.co: GVK Biosciences: Pushing the Envelope
Queries? Comments? E: corpcomm@aragen.com
